Does EPCORITAMAB-BYSP Cause Diffuse large b-cell lymphoma? 206 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Diffuse large b-cell lymphoma have been filed in association with EPCORITAMAB-BYSP. This represents 21.1% of all adverse event reports for EPCORITAMAB-BYSP.
206
Reports of Diffuse large b-cell lymphoma with EPCORITAMAB-BYSP
21.1%
of all EPCORITAMAB-BYSP reports
112
Deaths
25
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From EPCORITAMAB-BYSP?
Of the 206 reports, 112 (54.4%) resulted in death, 25 (12.1%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB-BYSP. However, 206 reports have been filed with the FAERS database.
What Other Side Effects Does EPCORITAMAB-BYSP Cause?
Cytokine release syndrome (369)
Diffuse large b-cell lymphoma refractory (198)
Pyrexia (79)
Immune effector cell-associated neurotoxicity syndrome (77)
Covid-19 (39)
Neutrophil count decreased (35)
Hypogammaglobulinaemia (32)
Platelet count decreased (32)
Cytomegalovirus infection (31)
Pneumonia (29)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which EPCORITAMAB-BYSP Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
EPCORITAMAB-BYSP vs EPERISONE
EPCORITAMAB-BYSP vs EPHEDRINE
EPCORITAMAB-BYSP vs EPINASTINE
EPCORITAMAB-BYSP vs EPINEPHRINE
EPCORITAMAB-BYSP vs EPINEPHRINE\LIDOCAINE